fashion -WSS

fashion

author：focus 2025-09-30 06:09:09 - browse：275

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Artificial intelligence use in health care faces greater scrutiny in 2024

focus

WSS

Hilary may become 1st tropical storm to make landfall in California in 84 years

Juul documents reveal insider tactics on political lobbying

Congress might make insulin pumps more accessible to the blind

Trump's false claims about Georgia's 2020 election long debunked

Bernie Sanders gets little from pharma CEOs on drug prices

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

entertainment

fashion

Wikipedia

Supreme Court strikes down use of affirmative action

Congress must protect the remaining independent doctors

Hollywood unions extend contract negotiations for actors

ACIP vaccine advisory panel sees its vacancies filled

Apple is now the first public company to be valued at $3 trillion

Evacuations in place as 3 wildfires burn in eastern Washington state

Tori Bowie and the unacceptable rates of Black maternal death

Baltimore teen accused of firing into crowd during block party mass shooting

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patient advocates sound warning on FDA proposal on salt intake

leisure time

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Artificial intelligence use in health care faces greater scrutiny in 2024

New definition of a human embryo proposed amid rapid advances

Living with Hashimoto's and celiac disease, and med school, too

Patient advocates sound warning on FDA proposal on salt intake

Juul documents reveal insider tactics on political lobbying

focus

entertainment

hotspot

entertainment